Bewelab SA

Bewe transforms metabolic health through neuroscience-based brain retraining. With 538M people living with diabetes and 3.2B overweight, diet-related conditions drive a global crisis. Bewe’s patented platform, backed by 15 years of research, uses gamified mobile tasks to rewire the brain’s reward system, reducing cravings without willpower. Validated by 4 RCTs (n>550), results show a 28% reduction in consumption and 50% fewer diet failures. 30% of users report elimination of trigger food intake in early real-world data. Winner of the 2026 Pfizer Research Prize, Bewe is live in the US, CH, and Benelux with 11k+ users and 10+ strategic partnerships. Led by serial entrepreneur Frederik Plourde (CEO) and Prof. Lucas Spierer (CSO), Bewe offers a scalable standard for metabolic care.